source name	characteristics[organism]	characteristics[organism part]	characteristics[strain/breed]	characteristics[developmental stage]	Characteristics[disease]	characteristics[sex]	characteristics[ancestry category]	characteristics[age]	Characteristics[cultured cell]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[individual]	Characteristics[biological replicate]	assay name	comment[file]	comment[label]	comment[fractionation method]	comment[fraction identifier]	comment[ms2 mass analyzer]	comment[instrument]	comment[separation]	comment[file uri]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]	Material Type
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 1	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc1 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 2	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 3	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 4	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 5	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 6	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 7	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 8	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 9	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 10	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc2 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 11	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 12	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 13	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 14	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 15	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 16	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc3 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 17	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc4 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 18	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc5 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 19	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 20	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 21	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 22	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 23	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 24	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 25	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 26	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 27	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 28	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 29	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 30	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 31	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 32	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 33	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 34	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 35	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 36	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 37	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 38	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 39	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 40	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 41	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 42	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 43	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 44	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 45	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 46	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 47	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 48	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 49	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 50	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 51	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 52	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 53	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 54	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 55	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 56	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 57	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 58	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 59	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 60	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 61	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 62	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 63	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 64	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 65	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 66	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 67	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 68	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 69	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 70	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 71	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 72	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 73	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 74	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 75	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 76	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 77	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 78	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 79	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 80	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 81	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 82	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 83	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 84	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 85	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 86	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 87	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 88	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 89	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 90	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 91	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 92	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 93	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 94	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 95	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 96	20161017_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 97	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 98	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F10_170503153643.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 99	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 100	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 101	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 102	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 103	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 104	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 105	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 106	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 107	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 108	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 109	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 110	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 111	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 112	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 113	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 114	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 115	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 116	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 117	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 118	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 119	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	run 120	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 121	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F1_170427224508.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 122	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 123	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 124	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 125	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 126	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 127	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 128	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 129	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 130	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 131	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 132	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F2_170427235251.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 133	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 134	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 135	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 136	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 137	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 138	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F3_170428010030.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 139	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F4_170428020817.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 140	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 141	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 142	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 143	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	run 144	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 145	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 146	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 147	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 148	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 149	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 150	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 151	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 152	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 153	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 154	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 155	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 156	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 157	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 158	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 159	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 160	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 161	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 162	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 163	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 164	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 165	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 166	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 167	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	run 168	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	1	run 169	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_1_A1_170407145349.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	1	run 170	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	1	run 171	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	1	run 172	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	1	run 173	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_13_B1_170410214309.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	1	run 174	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_14_B2_170410172255.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	1	run 175	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	1	run 176	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	1	run 177	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_17_B5_170410193253.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	1	run 178	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_18_B6_170411020408.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	1	run 179	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_19_B7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	1	run 180	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_2_A2_170411115256.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	1	run 181	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	1	run 182	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	1	run 183	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	1	run 184	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_23_B11_170411083623.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	1	run 185	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_24_B12_170411005852.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	1	run 186	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	1	run 187	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_26_C2_170411182553.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	1	run 188	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	1	run 189	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	1	run 190	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_3_A3_170410151303.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	1	run 191	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	1	run 192	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_31_C6_170410140811.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	1	run 193	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_32_C7_170410130315.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	1	run 194	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_33_C8_170410235334.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	1	run 195	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	1	run 196	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	1	run 197	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	1	run 198	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_37_C12_170411193130.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	1	run 199	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	1	run 200	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_39_D2_170411041450.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	1	run 201	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	1	run 202	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	nan	not available	62	not available	not available	not available	41	1	run 203	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	1	run 204	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	1	run 205	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	1	run 206	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	1	run 207	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	1	run 208	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_46_D9_170407155901.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	1	run 209	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	1	run 210	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	1	run 211	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_49_D12_170411030928.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	1	run 212	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	1	run 213	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_50_E1_170410203801.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	1	run 214	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	1	run 215	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_52_E3_170410224820.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	1	run 216	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	1	run 217	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	1	run 218	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	1	run 219	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_56_E7_170410182751.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	1	run 220	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	1	run 221	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_58_E9_170411161451.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	1	run 222	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_59_E10_170411073057.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	1	run 223	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	1	run 224	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	1	run 225	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	1	run 226	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	1	run 227	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_63_F2_170410161757.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	1	run 228	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	1	run 229	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	1	run 230	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_66_F5_170411094153.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	1	run 231	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	1	run 232	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	1	run 233	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	1	run 234	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_7_A7_170411140356.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	1	run 235	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	1	run 236	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_71_F10_170411150921.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	1	run 237	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_72_F11_170411104724.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	1	run 238	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	1	run 239	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_74_G1_170410115825.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	1	run 240	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_75_G2_170411062533.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	1	run 241	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_76_G3_170411052011.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	1	run 242	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	1	run 243	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_78_G5_170411172027.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	1	run 244	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	1	run 245	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_9_A9_170411125828.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	2	run 246	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_1_A1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	2	run 247	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	2	run 248	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	2	run 249	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	2	run 250	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_13_B1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	2	run 251	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_14_B2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	2	run 252	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	2	run 253	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	2	run 254	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_17_B5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	2	run 255	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_18_B6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	2	run 256	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_19_B7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	2	run 257	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_2_A2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	2	run 258	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	2	run 259	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	2	run 260	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	2	run 261	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_23_B11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	2	run 262	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_24_B12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	2	run 263	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	2	run 264	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_26_C2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	2	run 265	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	2	run 266	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	2	run 267	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_3_A3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	2	run 268	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	2	run 269	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_31_C6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	2	run 270	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_32_C7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	2	run 271	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_33_C8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	2	run 272	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	2	run 273	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	2	run 274	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	2	run 275	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_37_C12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	2	run 276	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	2	run 277	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_39_D2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	2	run 278	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	2	run 279	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	nan	not available	62	not available	not available	not available	41	2	run 280	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	2	run 281	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	2	run 282	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	2	run 283	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	2	run 284	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	2	run 285	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_46_D9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	2	run 286	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	2	run 287	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	2	run 288	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_49_D12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	2	run 289	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	2	run 290	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_50_E1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	2	run 291	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	2	run 292	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_52_E3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	2	run 293	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	2	run 294	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	2	run 295	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	2	run 296	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_56_E7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	2	run 297	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	2	run 298	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_58_E9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	2	run 299	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_59_E10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	2	run 300	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	2	run 301	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	2	run 302	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	2	run 303	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	2	run 304	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_63_F2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	2	run 305	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	2	run 306	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	2	run 307	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_66_F5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	2	run 308	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	2	run 309	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	2	run 310	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	2	run 311	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_7_A7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	2	run 312	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	2	run 313	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_71_F10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	2	run 314	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_72_F11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	2	run 315	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	2	run 316	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_74_G1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	2	run 317	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_75_G2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	2	run 318	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_76_G3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	2	run 319	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	2	run 320	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_78_G5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	2	run 321	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	2	run 322	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_9_A9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	3	run 323	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_1_A1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	3	run 324	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	3	run 325	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	3	run 326	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	3	run 327	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_13_B1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	3	run 328	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_14_B2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	3	run 329	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	3	run 330	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	3	run 331	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_17_B5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	3	run 332	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_18_B6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	3	run 333	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_19_B7_170418185445.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	3	run 334	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_2_A2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	3	run 335	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	3	run 336	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	3	run 337	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	3	run 338	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_23_B11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	3	run 339	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_24_B12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	3	run 340	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	3	run 341	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_26_C2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	3	run 342	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	3	run 343	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	3	run 344	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_3_A3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	3	run 345	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	3	run 346	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_31_C6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	3	run 347	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_32_C7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	3	run 348	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_33_C8_170420120643.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	3	run 349	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	3	run 350	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	3	run 351	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	3	run 352	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_37_C12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	3	run 353	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	3	run 354	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_39_D2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	3	run 355	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	3	run 356	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	nan	not available	62	not available	not available	not available	41	3	run 357	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	3	run 358	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	3	run 359	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	3	run 360	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	3	run 361	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	3	run 362	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_46_D9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	3	run 363	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	3	run 364	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	3	run 365	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_49_D12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	3	run 366	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	3	run 367	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_50_E1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	3	run 368	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	3	run 369	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_52_E3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	3	run 370	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	3	run 371	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	3	run 372	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	3	run 373	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_56_E7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	3	run 374	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	3	run 375	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_58_E9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	3	run 376	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_59_E10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	3	run 377	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	3	run 378	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	3	run 379	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	3	run 380	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	3	run 381	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_63_F2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	3	run 382	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	3	run 383	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	3	run 384	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_66_F5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	3	run 385	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	3	run 386	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	3	run 387	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	3	run 388	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_7_A7.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	3	run 389	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	3	run 390	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_71_F10.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	3	run 391	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_72_F11.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	3	run 392	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	3	run 393	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_74_G1.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	3	run 394	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_75_G2.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	3	run 395	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_76_G3.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	3	run 396	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	3	run 397	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_78_G5.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	3	run 398	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	3	run 399	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_9_A9.raw	AC=MS:1002038;NT=label free sample	not available	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)		AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm		